A 72-year-old Indian man with BPH is counselled about medical management options. Which finding best distinguishes between alpha-1 adrenergic antagonists and 5-alpha reductase inhibitors in terms of their mechanism and clinical effect?

Question

Accepted Answer

C. Alpha-blockers provide rapid symptom relief within days, while 5-alpha reductase inhibitors require months to reduce prostate volume. ## Alpha-Blockers vs 5-Alpha Reductase Inhibitors

### Mechanism and Timeline of Action

**Key Point:** The onset and mechanism of symptom relief differ fundamentally between these two drug classes, making timeline the best discriminator.

| Parameter | Alpha-1 Blockers | 5-Alpha Reductase Inhibitors |
|-----------|------------------|------------------------------|
| **Mechanism** | Relax smooth muscle in prostatic urethra | Inhibit DHT-mediated prostate growth |
| **Onset of symptom relief** | 1–3 days | 3–6 months |
| **Prostate volume reduction** | Minimal (<5%) | 20–30% over 6–12 months |
| **Effect on LUTS** | Rapid improvement | Gradual improvement |
| **Best use** | Acute/moderate LUTS | Prevention of progression, large prostate |

### Clinical Pharmacology

**High-Yield:** 
- **Alpha-blockers** (doxazosin, tamsulosin, terazosin) work by **relaxing smooth muscle** in the prostatic capsule and bladder neck. This provides **rapid symptom relief within 24–72 hours**, independent of prostate size.
- **5-alpha reductase inhibitors** (finasteride, dutasteride) work by **blocking conversion of testosterone to DHT**, thereby shrinking the prostate. This takes **3–6 months** to become clinically apparent and requires a **large prostate (>30–40 g)** to be effective.

### Clinical Applications

**Clinical Pearl:** 
- Alpha-blockers are first-line for symptomatic relief in all men with BPH-related LUTS.
- 5-alpha reductase inhibitors are reserved for men with **large prostates** (>40 g on ultrasound) or those at risk of progression (elevated PSA, family history of BPH).
- Combination therapy (alpha-blocker + 5-alpha reductase inhibitor) is used in men with large prostates and moderate-to-severe LUTS.

**Mnemonic:** **FAST vs SLOW** — Alpha-blockers are FAST (days), 5-alpha reductase inhibitors are SLOW (months).

Answer

A. Alpha-blockers prevent progression to acute urinary retention, while 5-alpha reductase inhibitors do not

Answer

B. Both reduce prostate volume equally over 3 months

Answer

D. 5-alpha reductase inhibitors are effective only in men with PSA >4 ng/mL

A 72-year-old Indian man with BPH is counselled about medical management options. Which finding best distinguishes between alpha-1 adrenergic antagonists and 5-alpha reductase inhibitors in terms of their mechanism and clinical effect?

Explanation

Practice similar questions